It just highlights the point that what works for some people, can make things worse for others (and vise- versa)
The decision to restart, switch to a different GLP-1 compound, or try a dual-peptide formulation depends on your goals, tolerability, and response to the first treatment
Semaglutide represents a significant evolution in the medical treatment of obesity, offering durable weight loss and meaningful metabolic benefits
International Journal of Molecular Sciences, 13(1), 518-533
Retatrutide is a synthetic triple-receptor agonist peptide targeting the GLP-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR) simultaneously, studied extensively across metabolic biology, obesity research, energy expenditure, and cardiovascular science for its unmatched tri-agonist incretin action and superior metabolic influence compared to single and dual-receptor compounds making it the most advanced and broadly acting incretin research peptide currently available in modern metabolic science
The abdominoplasty involves eliminating this excess skin and fat and repairing separated abdominal muscles